Selective Membrane Protein Enrichment Enables Defined Biomimetic Nanoparticles for Endothelial Targeting
Small · 2026-02 · 22 (11)
DOI: 10.1002/smll.202513548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 12.01.2026. Verfasst von Sivan Arber Raviv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bioinspired Nano Engineering and Translational Therapeutics Lab, Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa, …. Hauptthemen laut MEDLINE: Nanoparticles, Membrane Proteins, Biomimetics, Biomimetic Materials. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation award, Russell Berrie Nanotechnology Institute, Technion EVPR Fund: Nahum Wilbush Research Fund.
Abstract (Originalsprache)
Nanoparticles offer a promising strategy for targeted drug delivery while reducing off‐target toxicity. Biomimetic nanoparticles, which integrate native cell components, enhance biological compatibility but often suffer from poorly defined protein compositions that hinder reproducibility and clinical translation. Here, we present a next‐generation biomimetic approach to engineer Particular Nanoparticles (PNPs)‐ formulation enriched with specific, functionally relevant membrane proteins for precise control and tunability. We incorporated leukocyte adhesion proteins (including CD18, CD11a, and CD11b) into the nanoparticle membrane to enhance targeting of inflamed sites. Using a 2D microfluidic model that mimics human blood vessels, adhesion‐enriched PNPs demonstrated significantly improved endothelial interactions and greater accumulation under flow at inflamed endothelium compared to conventional Leukosomes. This protein‐defined biomimetic nanoparticle platform offers enhanced targeting efficiency, improved reproducibility, and translational potential for inflammation‐targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinspired Nano Engineering and Translational Therapeutics Lab, Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa, Israel.
- Russell-Berrie Nanotechnology Institute, Technion - Israel Institute of Technology, Haifa, Israel.
- Cardiovascular Sciences Department, Houston Methodist Academic Institute, Houston, Texas, USA.
- Neurosurgery Department, Houston Methodist Academic Institute, Houston, Texas, USA.
- Resnick Sustainability Center of Catalysis, Technion-Israel Institute of Technology, Haifa, Israel.
- Bruce and Ruth Rappaport Cancer Research Center, Technion-Israel Institute of Technology, Haifa, Israel.
ORCID-Profile: Assaf Zinger
Förderung
- Israel Science Foundation award
- Russell Berrie Nanotechnology Institute
- Technion EVPR Fund: Nahum Wilbush Research Fund
- Israel Cancer Research Foundation award
- Norman Seiden Fellowship in Nanotechnology and Optoelectronics
- Alon Fellowship
- ERC-Stg
- Israel Cancer Association award
Zitieren
APA
Raviv, S. A., Mhajne, R., Ben-Eliezer, M., Gross Lev, T., & Zinger, A. (2026). Selective Membrane Protein Enrichment Enables Defined Biomimetic Nanoparticles for Endothelial Targeting. Small, 22(11). https://doi.org/10.1002/smll.202513548
Vancouver
Raviv SA, Mhajne R, Ben-Eliezer M, Gross Lev T, Zinger A. Selective Membrane Protein Enrichment Enables Defined Biomimetic Nanoparticles for Endothelial Targeting. Small. 2026;22(11). doi:10.1002/smll.202513548
BibTeX
@article{Raviv2026,
author = {Raviv, Sivan Arber and Mhajne, Rawan and Ben-Eliezer, Maayan and Gross Lev, Tamar and Zinger, Assaf},
title = {Selective Membrane Protein Enrichment Enables Defined Biomimetic Nanoparticles for Endothelial Targeting},
journal = {Small},
year = {2026},
volume = {22},
number = {11},
doi = {10.1002/smll.202513548}
}
EUVIMED